Health

Scholars discuss the regulatory landscape surrounding genetic data privacy.

FDA approves first over-the-counter continuous glucose monitor for U.S. patients.

Scholars discuss EMTALA’s effects on physicians and argue for its continued use.

Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care.

Noah Aleshire, chief regulatory officer at the CDC, discusses the value of a collaborative and informed regulatory process.

FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.

Scholars, politicians, and advocates expose maternal health care disparities and propose regulatory solutions.

The Court rejected a challenge to FDA approval of mifepristone, but other obstacles could still impede access.

Scholars assess the state of food-additive regulation.

Scholars urge state lawmakers to strengthen driving regulations for seniors to address public safety concerns.

Scholars and practitioners debate whether and how to regulate off-label drug use.

Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.